欧盟CLP化学品分类名单

HazardClassandCategoryCode(s)HazardStatementCode(s)001-001-00-9hydrogen215-605-71333-74-0Flam.Gas1Press.GasH220001-002-00-4aluminiumlithiumhydride240-877-916853-85-3Water-react.1SkinCorr.1AH260H314001-003-00-Xsodiumhydride231-587-37646-69-7Water-react.1H260001-004-00-5calciumhydride232-189-27789-78-8Water-react.1H260003-001-00-4lithium231-102-57439-93-2Water-react.1SkinCorr.1BH260H314003-002-00-Xn-hexyllithium404-950-021369-64-2Water-react.1Pyr.Sol.1SkinCorr.1AH260H250H314003-003-00-5(2-methylpropyl)lithium;isobutyllithium440-620-2920-36-5Water-react.1Pyr.Liq.1SkinCorr.1ASTOTSE3AquaticAcute1AquaticChronic1H260H250H314H336H400H410004-001-00-7beryllium231-150-77440-41-7Carc.1BAcuteTox.2*AcuteTox.3*STOTRE1EyeIrrit.2STOTSE3SkinIrrit.2SkinSens.1H350iH330H301H372**H319H335H315H317004-002-00-2berylliumcompoundswiththeexceptionofaluminiumberylliumsilicates,andwiththosespecifiedelsewhereinthisAnnex--Carc.1BAcuteTox.2*AcuteTox.3*STOTRE1EyeIrrit.2STOTSE3SkinIrrit.2SkinSens.1AquaticChronic2H350iH330H301H372**H319H335H315H317H411004-003-00-8berylliumoxide215-133-11304-56-9Carc.1BAcuteTox.2*AcuteTox.3*STOTRE1EyeIrrit.2STOTSE3SkinIrrit.2SkinSens.1H350iH330H301H372**H319H335H315H317005-001-00-Xborontrifluoride231-569-57637-07-2Press.GasAcuteTox.2*SkinCorr.1AH330H314005-002-00-5borontrichloride233-658-410294-34-5Press.GasAcuteTox.2*AcuteTox.2*SkinCorr.1BH330H300H314005-003-00-0borontribromide233-657-910294-33-4AcuteTox.2*AcuteTox.2*SkinCorr.1AH330H300H314IndexNooInternationalChemicalIdentificationECNoCASNoClassification005-004-00-6trialkylboranes--Pyr.Sol.1SkinCorr.1BH250H314005-004-01-3trialkylboranes,liquid--Pyr.Liq.1SkinCorr.1BH250H314005-005-00-1trimethylborate204-468-9121-43-7Flam.Liq.3AcuteTox.4*H226H312005-006-00-7dibutyltinhydrogenborate401-040-575113-37-0Repr.1BMuta.2STOTRE1AcuteTox.4*AcuteTox.4*EyeDam.1SkinSens.1AquaticAcute1AquaticChronic1H360FDH341H372**H312H302H318H317H400H410005-007-00-2boricacid;[1]boricacid,crudenatural,containingnotmorethan85percentofH3BO3calculatedonthedryweight[2]233-139-2[1]234-343-4[2]10043-35-3[1]11113-50-1[2]Repr.1BH360FD005-008-00-8diborontrioxide;boricoxide215-125-81303-86-2Repr.1BH360FD005-009-00-3tetrabutylammoniumbutyltriphenylborate418-080-4120307-06-4SkinSens.1AquaticAcute1AquaticChronic1H317H400H410005-010-00-9N,N-dimethylaniliniumtetrakis(pentafluorophenyl)borate422-050-6118612-00-3Carc.2AcuteTox.4*SkinIrrit.2EyeDam.1H351H302H315H318005-011-00-4disodiumtetraborate,anhydrous;boricacid,disodiumsalt;[1]tetraborondisodiumheptaoxide,hydrate;[2]orthoboricacid,sodiumsalt[3]215-540-4[1]235-541-3[2]237-560-2[3]1330-43-4[1]12267-73-1[2]13840-56-7[3]Repr.1BH360FD005-011-01-1disodiumtetraboratedecahydrate;boraxdecahydrate215-540-41303-96-4Repr.1BH360FD005-011-02-9disodiumtetraboratepentahydrate;boraxpentahydrate215-540-412179-04-3Repr.1BH360FD005-012-00-Xdiethyl{}{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}}ammoniumbutyltriphenylborate418-070-1141714-54-7SkinSens.1AquaticAcute1AquaticChronic1H317H400H410005-013-00-5diethylmethoxyborane425-380-97397-46-8Pyr.Liq.1AcuteTox.4*AcuteTox.4*AcuteTox.4*STOTRE2*SkinCorr.1BSkinSens.1AquaticChronic4H250H332H312H302H373**H314H317H413005-014-00-04-formylphenylboronicacid438-670-587199-17-5SkinSens.1H317005-015-00-61-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octanebis(tetrafluoroborate)414-380-4140681-55-6AcuteTox.4*EyeDam.1SkinSens.1AquaticChronic3H302H318H317H412005-016-00-1tetrabutylammoniumbutyltris-(4-tert-butylphenyl)borate431-370-5-AquaticChronic4H413005-017-00-7sodiumperborate;[1]perboricacid,sodiumsalt;[2]perboricacid,sodiumsalt,monohydrate;sodiumperoxometaborate;perboricacid(HBO(O2)),sodiumsalt,monohydrate;sodiumperoxoborate;[containing0.1%(w/w)ofparticleswithanaerodynamicdiameterofbelow50μm]239-172-9[1]231-556-4[2]----15120-21-5[1]7632-04-4[2]----Oxid.Sol.2Repr.1BAcuteTox.4*STOTSE3EyeDam.1H272H360DfH302H335H318005-017-01-4sodiumperborate;[1]perboricacid,sodiumsalt;[2]perboricacid,sodiumsalt,monohydrate;sodiumperoxometaborate;perboricacid(HBO(O2)),sodiumsalt,monohydrate;sodiumperoxoborate;[containing≥0.1%(w/w)ofparticleswithanaerodynamicdiameterofbelow50μm]239-172-9[1]231-556-4[2]----15120-21-5[1]7632-04-4[2]----Oxid.Sol.2Repr.1BAcuteTox.3*AcuteTox.4*STOTSE3EyeDam.1H272H360DfH331H302H335H318005-018-00-2perboricacid(H3BO2(O2)),monosodiumsalttrihydrate;[1]perboricacid,sodiumsalt,tetrahydrate;[2]perboricacid(HBO(O2)),sodiumsalt,tetrahydrate;[3]sodiumperoxoboratehexahydrate;[containing0.1%(w/w)ofparticleswithanaerodynamicdiameterofbelow50μm]239-172-9[1]234-390-0[2]231-556-4[3]-13517-20-9[1]37244-98-7[2]10486-00-7[3]-Repr.1BSTOTSE3EyeDam.1H360DfH335H318005-018-01-Xperboricacid(H3BO2(O2)),monosodiumsalt,trihydrate;[1]perboricacid,sodiumsalt,tetrahydrate;[2]perboricacid(HBO(O2)),sodiumsalt,tetrahydrate;[3]sodiumperoxoboratehexahydrate;[containing≥0.1%(w/w)ofparticleswithanaerodynamicdiameterofbelow50μm]239-172-9[1]234-390-0[2]231-556-4[3]-13517-20-9[1]37244-98-7[2]10486-00-7[3]-Repr.1BAcuteTox.4*STOTSE